Jeffrey P. George is Director of Amneal Pharmaceuticals, Inc.. Currently has a direct ownership of 269,537 shares of AMRX, which is worth approximately $2.3 Million. The most recent transaction as insider was on May 10, 2024, when has been sold 76,453 shares (Class A Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 270K
0% 3M change
39.6% 12M change
Total Value Held $2.3 Million

Jeffrey P. George Transaction History

Date Transaction Value Shares Traded Shares Held Form
May 10 2024
BUY
Exercise of conversion of derivative security
-
76,453 Added 22.1%
269,537 Class A Common Stock
May 10 2023
BUY
Exercise of conversion of derivative security
-
80,128 Added 29.33%
193,084 Class A Common Stock
May 08 2022
BUY
Exercise of conversion of derivative security
-
35,406 Added 23.86%
112,956 Class A Common Stock
May 06 2021
BUY
Exercise of conversion of derivative security
-
46,218 Added 37.34%
77,550 Class A Common Stock
Dec 15 2020
BUY
Exercise of conversion of derivative security
-
7,522 Added 19.36%
31,332 Class A Common Stock

Also insider at

MASS
908 Devices Inc. Healthcare
GRPH
Graphite Bio, Inc. Healthcare
JPG

Jeffrey P. George

Director
Boston, MA

Track Institutional and Insider Activities on AMRX

Follow Amneal Pharmaceuticals, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells AMRX shares.

Notify only if

Insider Trading

Get notified when an Amneal Pharmaceuticals, Inc. insider buys or sells AMRX shares.

Notify only if

News

Receive news related to Amneal Pharmaceuticals, Inc.

Track Activities on AMRX